“Redeye reviews its assessment of Calmark to acknowledge the rapid establishment of the company’s commercial infrastructure on several markets and the prospects for its COVID19-LDH test. We hike our fair value range owing to this more optimistic take on the case.“
Read the full update: https://www.redeye.se/research/824617/calmark-untapped-potential
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.